Detalhe da pesquisa
1.
Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.
Platelets
; 34(1): 2195016, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37013676
2.
Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia.
Res Pract Thromb Haemost
; 7(3): 100134, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37193124